Giardiasis in pediatric populations: A case series highlighting nutritional and growth impacts Authors: Mayuri P. Bhise, Abhishek Padhi, Anil Chaudhary, Bhoomika Rajyaguru, Kinjal Chauhan, Pinky Meena, Ashwini Agrawal Published: 2025 ABSTRACT ABSTRACTGiardiasis, a common cause of parasitic diarrhea, is caused by the protozoan parasite Giardia lamblia (Giardia intestinalis or Giardia duodenalis). This intestinal flagellate protozoan is prevalent among children worldwide and is a significant source of traveller’s diarrhea. It is estimated that there are about 2.5 million cases of giardiasis-related diarrhea and nutritional deficits in children every year, with the majority occurring in developing countries. Since 2004, the World Health Organization has classified it as one of the neglected tropical diseases. Those most at risk for complications from giardiasis are children aged 1–5 years and undernourished individuals in developing countries who may experience malabsorption, weight loss, and growth retardation. The prevalence rates are expected to be around 2%–5% in developed countries and significantly higher at 20%–30% in developing countries. Here, we report the case series of seven pediatric children with various clinical presentations with failure to gain weight and abdominal pain being the most common among all the cases ultimately presenting with long-term sequelae like malnutrition and growth retardation. This case series underscores the importance of considering giardiasis in the differential diagnosis of pediatric patients presenting with growth retardation and gastrointestinal symptoms, particularly in endemic areas. Early diagnosis and appropriate treatment are crucial in mitigating the long-term health impacts of this neglected tropical disease. Background The protozoan parasite Giardia lamblia is the cause of giardiasis, which is a common cause of parasitic diarrhea that is especially common in children around the world. Additionally, it plays a big part in traveller’s diarrhea. Every year, some 2.5 million children suffer from nutritional deficiencies and diarrhea caused by giardiasis; underdeveloped nations are mostly responsible for this burden.[123] Since 2004, the World Health Organization has listed giardiasis as one of the neglected tropical diseases due to its significance. Children between the ages of 1 and 5 are most frequently affected by this parasite, particularly those who live in impoverished nations and are malnourished. Complications from this infection include malabsorption, weight loss, and growth retardation.[456] Although the estimated incidence in wealthy countries is between 2% and 5%, it might reach 20% to 30% in developing countries.[78] Giardiasis is a significant yet often overlooked cause of pediatric morbidity that primary care providers frequently encounter, especially in resource-limited settings. Children presenting with nonspecific symptoms such as abdominal pain, failure to thrive, and recurrent diarrhea pose diagnostic challenges, underscoring the need for primary care physicians to maintain a high index of suspicion. By understanding the clinical and nutritional impact of giardiasis, primary care physicians can contribute to timely diagnosis, appropriate management, and prevention of long-term sequelae in children. Giardia lamblia can have two different morphological forms: trophozoites and cysts. Trophozoites are binucleate, multiflagellated, and pear-shaped and capable of dividing through asexual binary fission. Because it is motile and active, this stage causes pathology in the small intestine. Cysts, on the other hand, are resistant, stable, and nonmotile forms that do not stick to the mucosal surface.[7] Human illness is caused by the fast-growing trophozoites that adhere to the walls of the small intestine. On the other hand, parasite cysts are not as contagious but are still quite important in the spread of illness. These cysts may also tolerate varying chlorine concentrations that are employed in water treatment facilities. Actually, 50% of carriers with symptoms have cysts that contain infection and allow it to spread. During microscopic stool analysis, the presence of the cyst or trophozoite provides a conclusive diagnosis of Giardia lamblia. The stool is typically unpleasant, thick, pale, nonbloody, mucoid (fatty), or watery when viewed macroscopically.[8] Giardia lamblia has the ability to create a variety of clinical signs, ranging from weight loss and malabsorption syndrome to acute or chronic diarrhea. A common cause of children’s persistent stomach pain is Giardia lamblia.[910] Consuming improperly treated polluted water, eating contaminated undercooked vegetables or unwashed fruits, and person-to-person transmission through the fecal-oral pathway are the main causes of illness. Inadequate living circumstances, congested housing, unsanitary surroundings, unclean personal practices, contaminated water sources, and low socioeconomic status are other contributing factors.[1] In high-income nations, where illnesses are typically linked to travel, a low prevalence rate is noted. In places with inadequate environmental and personal hygiene and sanitation, the incidence rate is high. The geographic location, the society’s urban or rural setting, the makeup of the age groups, and the socioeconomic circumstances may all have a role in the variance in prevalence.[11] Here, we report a case series of pediatric patients presenting various Giardiasis presentations. Case 1: A 4-year-old girl who had received all the recommended vaccinations for her age was brought in complaining of a slight fever and coryza for 2 days. There was a history of recurrent rhinorrhea brought on by cold exposure, occurring every 15 days for the previous 3 to 4 months and never being accompanied by a fever. There was no past medical history indicating the presence of serious respiratory or ear infections. Examining her further revealed that she looked thin for her age and height, and the child’s weight for height was discovered to be in the third percentile, indicating moderate wasting. When the mother is questioned more about the reason, she reveals that her child has not gained weight in the last year despite having a strong history of increased appetite. She has also experienced an increase in the frequency of bowel movements over the past year, passing stool three times a day after meals. However, there is no history of excessive urination, excessive thirst, abdominal pain, bloating, yellowing of the skin or eyes, fatty stools, constipation, or urinary issues. Upon examination, her vital signs were stable; the child did not exhibit paleness, yellowing of the skin or eyes, bluish discoloration, swollen lymph nodes, or other signs of malnutrition or swelling. Her systemic examination was normal; her thyroid was palpable as usual. Due to her inability to gain weight despite an increased appetite, slightly increased bowel movement frequency, and recurring rhinitis episodes, a stool sample was sent for microbiological examination, which revealed the following findings upon microscopy [Figure 1]. The possibility of Giardia infection was suspected due to the child’s inability to gain weight despite increased appetite and increased frequency of bowel movements from the past year. Stool microscopic examination demonstrated numerous cysts of Giardia lamblia. She was treated with metronidazole for 7 days (Metronidazole 200 mg oral tablet, 1/2 Tablet, TDS). Follow-up stool microscopic examinations done twice at a gap of 7 days were reported negative for Giardia lamblia. Stool wet mount in Saline mount (40×) Case 2: A 12-year-old boy fully immunized for his age was brought with complaints of abdominal pain and increased bowel movements for the past year. On further enquiring, the boy gave a detailed history of not gaining weight for the past year despite a significantly increased appetite. He gave an account of abdominal pain and worm passage for which he had received albendazole treatment. He had vitiligo and raised anti-thyroid peroxidase antibody levels, for which he was on steroids. He also received steroids in the past for the treatment of pre-vitiligo. There was no history of fever, severe respiratory infections, ear infection polyuria, polydipsia, distension, jaundice, steatorrhea, constipation, or urinary abnormalities. A family history of diabetes mellitus, hypothyroidism, gout, and vitiligo was present. On examination, the vitals were stable. The child’s milestones were normal except for the weight BMI of 17.7 (height – 10 percentile). Taking into account the above complaints of inability to gain weight despite increased appetite, increased frequency of bowel movement, vitiligo with raised anti-thyroid peroxidase antibody levels, and a family history giving strong autoimmune disorder connection, a stool sample was sent for microbiological examination, which on microscopy demonstrated the cysts of Giardia lamblia. He was treated with metronidazole for 7 days (Metronidazole 200 mg oral tablet, 1 Tablet, BD). Follow-up of stool microscopic examination was done at a gap of 7 days, which was negative for Giardialamblia. Case 3: A 9-year-old boy fully immunized for his age was brought with complaints of abdominal pain and increased bowel movements. There is a history of failure to gain weight and height proportionate to age. He gave a similar account of abdominal pain for which he had received albendazole treatment. A family history of similar complaints among the other siblings was obtained. So, a stool sample was sent for routine stool microscopy, which reported Giardia lamblia cysts [Figure 2]. Stool wet mount stained with Lugol’s Iodine (40×) Case 4: A 6-year-old female child fully immunized for her age was brought with complaints of dull aching peri umbilical pain for 8 days associated with increased bowel movements. She gave a similar recurrent history of abdominal pain. On enquiring about family history, similar complaints were there in her sibling. Because of the above scenario, the stool sample was sent for microbiological examination, which demonstrated the cysts of Giardia lamblia on microscopy. Case 5: An 8-year-old male child, fully immunized for age, was brought with complaints of abdominal pain. On further enquiring about the cause, the mother gives the history of a child not gaining weight for the past year despite a significant history of increased appetite. There was a history of recurrent rhinorrhea. A family history of diabetes mellitus, hypothyroidism, and hypertension was present. On examination, his vitals were stable; the child did not have pallor, icterus, cyanosis, lymphadenopathy, other signs of malnutrition, or edema. His systemic examination was routine. Considering his inability to gain weight despite increased appetite, abdominal pain, and recurrent episodes of rhinitis, a stool sample was sent for microbiological examination, which demonstrated numerous Giardia lamblia cysts on microscopy. Case 6: An 11-year-old male child fully immunized for his age was brought with complaints of dull aching abdominal pain. On enquiring about family history, similar complaints were there in her sibling. Because of the above scenario, the stool sample was sent for microbiological examination, which demonstrated the cysts of Giardia lamblia on microscopy. Case 7: A 7-year-old male child, fully immunized for age, was brought with complaints of abdominal pain and not gaining weight for the past year despite a significant history of increased appetite. On examination, his vitals were stable; the child did not have pallor, icterus, cyanosis, lymphadenopathy, other signs of malnutrition, or edema. His systemic examination was routine. Considering his inability to gain weight despite increased appetite and abdominal pain, a stool sample was sent for microbiological examination, which demonstrated numerous Giardia lamblia cysts on microscopy. Discussion Giardiasis is a significant public health concern, particularly in pediatric populations in developing countries, where it contributes to high rates of morbidity, including malnutrition, growth retardation, and other gastrointestinal complications. This case series sheds light on the clinical manifestations of giardiasis among children, emphasizing its diverse presentations and its substantial impact on child health. Clinical manifestations: Comparison with existing literature The children in this case series presented with a range of symptoms, most notably failure to gain weight, abdominal pain, and increased bowel movements. These symptoms are consistent with the classical presentation of giardiasis in children, as reported in previous studies. For instance, a study by Cacciò et al.[12] highlighted that chronic diarrhea, abdominal discomfort, and weight loss are common in children with giardiasis, often leading to more severe conditions such as malabsorption syndromes and failure to thrive.[12] The chronic nature of these symptoms in our cases, spanning several months to a year, underscores the potential for giardiasis to cause persistent and debilitating illness in children, particularly in resource-limited settings where access to timely diagnosis and treatment may be limited. Additionally, the presence of recurrent rhinorrhoea in several of our cases, although not a direct symptom of giardiasis, may reflect the broader immune dysregulation caused by chronic parasitic infections. Escobedo et al.[13] reported that children with giardiasis often exhibit increased susceptibility to respiratory infections, potentially due to the immune modulation effects of the parasite.[13] This finding suggests that giardiasis may have broader systemic effects beyond the gastrointestinal tract, contributing to overall morbidity in affected children. Diagnostic challenges and treatment outcomes In this series, the diagnosis of giardiasis was confirmed through stool microscopy, revealing the presence of Giardia lamblia cysts. This method remains the gold standard for diagnosing giardiasis, despite the challenges associated with intermittent cyst shedding, which can lead to false negatives if only a single stool sample is examined. Multiple stool samples may increase the diagnostic yield, as noted by Garcia et al.,[14] who emphasized the need for repeated sampling to detect Giardia lamblia in cases with low cyst excretion. The successful treatment of giardiasis in all cases with metronidazole, a first-line therapy, reinforces the effectiveness of this treatment regimen. The follow-up stool examinations, which were negative for Giardia, provide further evidence of treatment efficacy. Gardner and Hill[15] also supported the use of metronidazole as the standard of care for giardiasis, noting its high cure rates and broad activity against Giardia. However, the potential for metronidazole resistance, although rare, should be monitored, particularly in areas where giardiasis is endemic. Impact on growth and nutrition: A critical concern One of the most concerning findings in this case series is the significant association between giardiasis and growth retardation in children. Nearly all the children in this series exhibited failure to gain weight despite having a normal or increased appetite. This observation is particularly alarming given the crucial role of adequate nutrition and growth during childhood. Malnutrition during early childhood can have lasting consequences, including impaired cognitive development, weakened immunity, and increased susceptibility to other infections. Al-Mekhlafi et al.[16] highlighted the severe impact of giardiasis on child growth, particularly in malnourished populations, where the parasite exacerbates existing nutritional deficiencies. Giardiasis can lead to malabsorption of essential nutrients, such as fats, carbohydrates, and vitamins, further compounding the nutritional challenges faced by children in low-resource settings. The fact that some of the children in our series had pre-existing conditions, such as vitiligo and raised anti-thyroid peroxidase antibody levels, raises the possibility of a more complex interaction between giardiasis and autoimmune disorders. This interaction warrants further investigation to understand the broader implications of chronic parasitic infections on immune function and overall health. Strengths and limitations of the study This case series provides valuable insights into the clinical spectrum of giardiasis in pediatric patients, particularly in highlighting its impact on growth and nutritional status. The detailed clinical documentation and follow-up are key strengths of this study, allowing for a comprehensive understanding of the disease’s progression and response to treatment. However, the study is not without limitations. The small sample size limits the generalizability of the findings as it may not capture the full range of clinical presentations associated with giardiasis. Additionally, the reliance on stool microscopy, while effective, may have led to under diagnosis in cases where cyst shedding was minimal or inconsistent. The absence of more advanced diagnostic methods, such as enzyme immunoassays or molecular techniques, is another limitation that could have provided a more accurate diagnosis. Future research directions Given the significant burden of giardiasis on child health, particularly in low-resource settings, further research is needed to explore the long-term outcomes of children affected by this parasite. Longitudinal studies that track the growth, cognitive development, and overall health of children post-treatment are essential to fully understand the impact of giardiasis. Moreover, research into the potential interactions between giardiasis and autoimmune disorders could provide new insights into the broader health implications of chronic parasitic infections. In addition, future studies should consider the use of more advanced diagnostic techniques, such as polymerase chain reaction (PCR) or antigen detection assays, to improve the accuracy and sensitivity of giardiasis diagnosis. These methods could be particularly valuable in settings where stool microscopy is not readily available or where intermittent cyst shedding complicates diagnosis. Primary care physicians are pivotal in the early recognition and management of giardiasis, particularly in pediatric populations. The nonspecific nature of symptoms such as abdominal pain, recurrent diarrhea, and failure to thrive can make diagnosis challenging. This study underscores the role of stool microscopy as an accessible diagnostic tool in resource-limited settings. Furthermore, the successful treatment outcomes using metronidazole align with current guidelines and provide actionable insights for clinical management. Beyond treatment, primary care physicians can play a critical role in counseling families about the importance of hygiene, safe drinking water, and sanitation practices to prevent a recurrence, particularly in endemic regions. These findings aim to enhance the capacity of primary care providers to address giardiasis effectively within their communities. Conclusion This case series underscores the importance of considering giardiasis in the differential diagnosis of pediatric patients presenting with growth retardation and gastrointestinal symptoms, particularly in endemic areas. Early diagnosis and appropriate treatment are crucial in mitigating the long-term health impacts of this neglected tropical disease. As giardiasis continues to be a significant public health concern, particularly in resource-limited settings, ongoing efforts to improve diagnostic capabilities and treatment strategies are essential to protect the health and wellbeing of children worldwide. Authors’ contributions Dr. Mayuri Bhise: Writing the original Draft Conceptualisation, formal analysis, and resourcesDr. Abhishek Padhi: Writing the original Draft ValidationDr. Anil Chaudhary: ResourcesDr. Bhoomika Rajyaguru: ResourcesDr. Kinjal Chauhan: ResourcesDr. Pinky Meena: Formal analysis, ResourcesDr. Ashwini Agarwal: Review, Supervision Validation Dr. Mayuri Bhise: Writing the original Draft Conceptualisation, formal analysis, and resources Dr. Mayuri Bhise: Writing the original Draft Conceptualisation, formal analysis, and resources Dr. Abhishek Padhi: Writing the original Draft Validation Dr. Abhishek Padhi: Writing the original Draft Validation Dr. Anil Chaudhary: Resources Dr. Anil Chaudhary: Resources Dr. Bhoomika Rajyaguru: Resources Dr. Bhoomika Rajyaguru: Resources Dr. Kinjal Chauhan: Resources Dr. Kinjal Chauhan: Resources Dr. Pinky Meena: Formal analysis, Resources Dr. Pinky Meena: Formal analysis, Resources Dr. Ashwini Agarwal: Review, Supervision Validation Dr. Ashwini Agarwal: Review, Supervision Validation Ethical statement The authors confirm that the ethical policies of the journal have been adhered to. Ethical approval was taken by the Institutional Ethics Committee. (IEC Approval Number: -IEC/AIIMS/RAJKOT/5th/ER/05. No identification details of the patient have been shared in the article. Availability of data and materials Data was made available by the corresponding author. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Conflict of interest The authors declare no conflict of interest.